Capitol Hill Sen. Durbin weighs in on the controversy about dosage of Amgen drug sotorasib May 17, 2024Vol.50 No.20By Paul Goldberg
Guest Editorial Regulators must step in to safeguard patient data in the AI era May 17, 2024Vol.50 No.20By Mika Newton
Cancer History ProjectConversation with The Cancer LetterFree 2024 Karnofsky Award winner Lillian Siu talks about her career in phase I studies, ctDNA, and her mentor’s “evil red pencil” May 10, 2024Vol.50 No.19By Jacquelyn Cobb
Trials & Tribulations Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity May 10, 2024Vol.50 No.19By Sanju Sinha and Eytan Ruppin
Guest Editorial OCE’s Project 5 in 5 seeks to inspire pragmatic innovation May 10, 2024Vol.50 No.19By Steven C. Cunningham, Donna R. Rivera, Richard Pazdur, Kelly J. Norsworthy and Jennifer Gao
Guest Editorial Voices of Black women can improve cancer outcomes May 10, 2024Vol.50 No.19By Alpa V. Patel
FreeIn the Archives UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research May 10, 2024Vol.50 No.19
Conversation with The Cancer LetterFree Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump May 03, 2024Vol.50 No.18By Paul Goldberg
Health EquityWhite House Citing need for “more conversations” on menthol, White House scuttles move to ban the flavor favored by Black smokers May 03, 2024Vol.50 No.18By McKenzie Prillaman
Conversation with The Cancer Letter USPSTF’s Wanda Nicholson: Final recommendation to start breast cancer screening at 40 will save 20% more lives May 03, 2024Vol.50 No.18By Matthew Bin Han Ong
